Market Overview

U.S. equity futures edged higher overnight amid ongoing Middle East tensions that have driven oil prices sharply higher, reigniting inflation concerns and keeping rate-cut expectations in check. Small-cap and micro-cap runners continue to dominate after-hours action with elevated relative volume in biotech, AI, and energy storage names as retail flows chase breakouts and known multi-day movers.

Asian markets mixed with Nikkei soft while Hang Seng firmed; watch CPI and earnings calendar for confirmation of risk-on continuation into the open.

1️⃣ $TGHL (The Growhub Limited) | ☁️ IT Services

Current Status:

• Price: $1.41 (+73.08%)
• Float: 12.72M
• Volume: 45.07M (high RVOL)
• Key Times: High 16:50 ET, Support test 15:30 ET

Trading Levels:

• Intraday Range: $0.79–$1.69
• Key Support: $1.20 (overnight), $1.00 (consolidation)
• Entry Zones: → $1.35 / $1.45

Entry Confirmation:

• Require 2+ consecutive 1m/5m closes above the entry zone with reversal or volume surge.
• Do NOT enter on first touch without confirmation.
• Targets: T1 $1.60 | T2 $1.80 | T3 $2.00 | T4 $2.25 | T5 $2.50
• Stop Loss: $1.20 (max 3–5% risk)
• Trailing Stop: 10% (5–15% scaled to volatility)

Technical Confirmation:

• Scanner Hits: BREAKOUT, MOMENTUM, Known Runner, FORM 6-K
• Volume: 45.07M shares, $59.54M dollar volume (extreme RVOL)
• Indicators: RSI 72, MACD bullish cross, OBV rising, above VWAP
• Pattern: Parabolic continuation (daily)
• Catalyst: Binding term sheet to acquire EnChem America in $400M deal — Reuters, recent

---

2️⃣ $ATAI (AtaiBeckley Inc.) | 🧬 Biotechnology

Current Status:

• Price: $8.91 (+66.23%)
• Float: 303.81M
• Volume: 4.77M (elevated RVOL)
• Key Times: High 16:20 ET, Support test 14:45 ET

Trading Levels:

• Intraday Range: $5.30–$9.01
• Key Support: $7.50 (overnight), $6.50 (consolidation)
• Entry Zones: → $8.20 / $8.60

Entry Confirmation:

• Require 2+ consecutive 1m/5m closes above the entry zone with reversal or volume surge.
• Do NOT enter on first touch without confirmation.
• Targets: T1 $9.50 | T2 $10.50 | T3 $11.50 | T4 $12.50 | T5 $14.00
• Stop Loss: $7.80 (max 3–5% risk)
• Trailing Stop: 8% (5–15% scaled to volatility)

Technical Confirmation:

• Scanner Hits: BREAKOUT, MOMENTUM, #1 multiple hits
• Volume: 4.77M shares, $39.82M dollar volume (high RVOL)
• Indicators: RSI 68, MACD bullish, OBV climbing, above VWAP
• Pattern: Multi-day momentum breakout (15m/1h)
• Catalyst: Phase 3 program alignment and BPL-003 updates — company filings, recent

---

3️⃣ $ATPC (Agape ATP Corporation) | 🔋 Energy

Current Status:

• Price: $3.61 (+43.25%)
• Float: 0.43M
• Volume: 1.72M (extreme RVOL)
• Key Times: High 16:10 ET, Support test 13:50 ET

Trading Levels:

• Intraday Range: $2.52–$3.87
• Key Support: $3.00 (overnight), $2.70 (consolidation)
• Entry Zones: → $3.40 / $3.55

Entry Confirmation:

• Require 2+ consecutive 1m/5m closes above the entry zone with reversal or volume surge.
• Do NOT enter on first touch without confirmation.
• Targets: T1 $3.90 | T2 $4.25 | T3 $4.75 | T4 $5.25 | T5 $6.00
• Stop Loss: $3.20 (max 3–5% risk)
• Trailing Stop: 12% (5–15% scaled to volatility)

Technical Confirmation:

• Scanner Hits: BREAKOUT, MOMENTUM, FORM SCH 13G, Known Runner
• Volume: 1.72M shares, $5.61M dollar volume (extreme RVOL)
• Indicators: RSI 75, MACD strong, OBV surge, above VWAP
• Pattern: Low-float parabolic (5m)
• Catalyst: Oil trading collaboration with Citadel Investment — company PR, March 2026 extended momentum

---

4️⃣ $HELP (Helus Pharma) | 🧬 Biotechnology

Current Status:

• Price: $7.61 (+16.86%)
• Float: 48.33M
• Volume: 0.29M (solid RVOL)
• Key Times: High 16:05 ET, Support test 15:10 ET

Trading Levels:

• Intraday Range: $6.51–$7.98
• Key Support: $7.00 (overnight), $6.60 (consolidation)
• Entry Zones: → $7.40 / $7.55

Entry Confirmation:

• Require 2+ consecutive 1m/5m closes above the entry zone with reversal or volume surge.
• Do NOT enter on first touch without confirmation.
• Targets: T1 $8.00 | T2 $8.50 | T3 $9.00 | T4 $9.75 | T5 $10.50
• Stop Loss: $7.10 (max 3–5% risk)
• Trailing Stop: 7% (5–15% scaled to volatility)

Technical Confirmation:

• Scanner Hits: #1 multiple, MOMENTUM
• Volume: 0.29M shares, $2.15M dollar volume (elevated RVOL)
• Indicators: RSI 62, MACD positive, OBV steady, above VWAP
• Pattern: Higher-high continuation (15m)
• Catalyst: Phase 3 APPROACH enrollment >88% and $50M offering close — GlobeNewswire, June 2026

---

5️⃣ $LNKS (Linkers Industries Limited) | 🏗️ Industrials

Current Status:

• Price: $1.58 (+18.79%)
• Float: 1.33M
• Volume: 0.19M (high RVOL)
• Key Times: High 15:55 ET, Support test 14:20 ET

Trading Levels:

• Intraday Range: $1.32–$1.63
• Key Support: $1.40 (overnight), $1.30 (consolidation)
• Entry Zones: → $1.50 / $1.55

Entry Confirmation:

• Require 2+ consecutive 1m/5m closes above the entry zone with reversal or volume surge.
• Do NOT enter on first touch without confirmation.
• Targets: T1 $1.70 | T2 $1.85 | T3 $2.00 | T4 $2.25 | T5 $2.50
• Stop Loss: $1.40 (max 3–5% risk)
• Trailing Stop: 10% (5–15% scaled to volatility)

Technical Confirmation:

• Scanner Hits: #1, Known Runner, IND
• Volume: 0.19M shares, $0.29M dollar volume (high RVOL)
• Indicators: RSI 65, MACD bullish, OBV rising, above VWAP
• Pattern: Tight flag breakout (1h)
• Catalyst: Stake increase in LPW Electronics to 49% — company announcement, recent

---

6️⃣ $JTAI (Jet.AI Inc.) | 🚀 Technology

Current Status:

• Price: $3.65 (+16.24%)
• Float: 1.42M
• Volume: 5.00M (extreme RVOL)
• Key Times: High 16:00 ET, Support test 12:30 ET

Trading Levels:

• Intraday Range: $2.76–$4.36
• Key Support: $3.20 (overnight), $3.00 (consolidation)
• Entry Zones: → $3.50 / $3.60

Entry Confirmation:

• Require 2+ consecutive 1m/5m closes above the entry zone with reversal or volume surge.
• Do NOT enter on first touch without confirmation.
• Targets: T1 $3.90 | T2 $4.25 | T3 $4.75 | T4 $5.25 | T5 $6.00
• Stop Loss: $3.30 (max 3–5% risk)
• Trailing Stop: 12% (5–15% scaled to volatility)

Technical Confirmation:

• Scanner Hits: MOMENTUM, BREAKOUT, whale alerts, high RV
• Volume: 5.00M shares, $18.56M dollar volume (extreme RVOL)
• Indicators: RSI 70, MACD strong, OBV surge, above VWAP
• Pattern: Low-float squeeze (5m/15m)
• Catalyst: Shareholder meeting and merger updates with Flyexclusive — company 8-K, recent

---

7️⃣ $EOSE (Eos Energy Enterprises) | 🔋 Energy Storage

Current Status:

• Price: $4.97 (+13.73%)
• Float: 335.13M
• Volume: 8.25M (solid RVOL)
• Key Times: High 15:40 ET, Support test 11:15 ET

Trading Levels:

• Intraday Range: $4.37–$5.25
• Key Support: $4.60 (overnight), $4.40 (consolidation)
• Entry Zones: → $4.80 / $4.95

Entry Confirmation:

• Require 2+ consecutive 1m/5m closes above the entry zone with reversal or volume surge.
• Do NOT enter on first touch without confirmation.
• Targets: T1 $5.25 | T2 $5.75 | T3 $6.25 | T4 $7.00 | T5 $8.00
• Stop Loss: $4.60 (max 3–5% risk)
• Trailing Stop: 8% (5–15% scaled to volatility)

Technical Confirmation:

• Scanner Hits: BREAKOUT, MOMENTUM, FORM 4/8-K cluster
• Volume: 8.25M shares, $40.16M dollar volume (elevated RVOL)
• Indicators: RSI 64, MACD positive, OBV rising, above VWAP
• Pattern: Cup-and-handle resolution (daily)
• Catalyst: Selected to deliver mission-ready power for Golden Dome + European partnership — company PR, recent

---

8️⃣ $VSA (VisionSys AI Inc.) | 🤖 Artificial Intelligence

Current Status:

• Price: $4.00 (+23.45%)
• Float: 0.62M
• Volume: 1.32M (extreme RVOL)
• Key Times: High 16:15 ET, Support test 13:00 ET

Trading Levels:

• Intraday Range: $3.23–$4.77
• Key Support: $3.60 (overnight), $3.40 (consolidation)
• Entry Zones: → $3.85 / $3.95

Entry Confirmation:

• Require 2+ consecutive 1m/5m closes above the entry zone with reversal or volume surge.
• Do NOT enter on first touch without confirmation.
• Targets: T1 $4.30 | T2 $4.75 | T3 $5.25 | T4 $5.75 | T5 $6.50
• Stop Loss: $3.60 (max 3–5% risk)
• Trailing Stop: 12% (5–15% scaled to volatility)

Technical Confirmation:

• Scanner Hits: BREAKOUT, Known Runner, R/S 1:10
• Volume: 1.32M shares, $5.61M dollar volume (extreme RVOL)
• Indicators: RSI 71, MACD bullish, OBV strong, above VWAP
• Pattern: Post-R/S momentum (15m)
• Catalyst: AI healthcare/biotech system updates and reverse-split clean-up — company filings, recent

---

9️⃣ $PBM (Psyence Biomedical Ltd.) | 🧬 Biotechnology

Current Status:

• Price: $3.55 (+24.00%)
• Float: 0.97M
• Volume: 0.39M (high RVOL)
• Key Times: High 15:20 ET, Support test 12:45 ET

Trading Levels:

• Intraday Range: $2.85–$4.10
• Key Support: $3.20 (overnight), $2.95 (consolidation)
• Entry Zones: → $3.40 / $3.50

Entry Confirmation:

• Require 2+ consecutive 1m/5m closes above the entry zone with reversal or volume surge.
• Do NOT enter on first touch without confirmation.
• Targets: T1 $3.80 | T2 $4.20 | T3 $4.75 | T4 $5.25 | T5 $6.00
• Stop Loss: $3.20 (max 3–5% risk)
• Trailing Stop: 10% (5–15% scaled to volatility)

Technical Confirmation:

• Scanner Hits: #1, Known Runner, IND
• Volume: 0.39M shares, $0.29M dollar volume (high RVOL)
• Indicators: RSI 69, MACD cross, OBV rising, above VWAP
• Pattern: Low-float runner continuation (5m)
• Catalyst: Psilocybin mental-health pipeline progress — company updates, recent

---

🔟 $FULC (Fulcrum Therapeutics, Inc.) | 🧬 Biotechnology

Current Status:

• Price: $3.76 (+5.00%)
• Float: 48.00M
• Volume: 0.11M (solid RVOL)
• Key Times: High 14:50 ET, Support test 11:40 ET

Trading Levels:

• Intraday Range: $3.56–$3.84
• Key Support: $3.60 (overnight), $3.50 (consolidation)
• Entry Zones: → $3.70 / $3.75

Entry Confirmation:

• Require 2+ consecutive 1m/5m closes above the entry zone with reversal or volume surge.
• Do NOT enter on first touch without confirmation.
• Targets: T1 $3.95 | T2 $4.25 | T3 $4.60 | T4 $5.00 | T5 $5.50
• Stop Loss: $3.55 (max 3–5% risk)
• Trailing Stop: 7% (5–15% scaled to volatility)

Technical Confirmation:

• Scanner Hits: #1, HALTED (news), FORM 4
• Volume: 0.11M shares, $0.40M dollar volume (elevated RVOL)
• Indicators: RSI 58, MACD flattening bullish, OBV positive, above VWAP
• Pattern: Base breakout (daily)
• Catalyst: Positive Phase 1b PIONEER trial data for pociredir in sickle cell — company PR, recent